Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
7.16
+0.16 (2.29%)
At close: Oct 14, 2024, 4:00 PM
6.81
-0.35 (-4.89%)
After-hours: Oct 14, 2024, 4:24 PM EDT
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $238.92 million as of October 14, 2024. Its market cap has increased by 300.20% in one year.
Market Cap
238.92M
Enterprise Value
159.33M
1-Year Change
300.20%
Ranking
Category
Stock Price
$7.16
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $238.92M, a decrease of -51.06%. That is a compound annual growth rate of -19.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 11, 2024 | 233.60M | 24.65% |
| Dec 29, 2023 | 187.40M | 379.28% |
| Dec 30, 2022 | 39.10M | -81.46% |
| Dec 31, 2021 | 210.90M | -56.80% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amarin Corporation | 242.59M |
| Amylyx Pharmaceuticals | 241.69M |
| Mersana Therapeutics | 241.67M |
| ModivCare | 237.38M |
| Enanta Pharmaceuticals | 233.92M |
| Solid Biosciences | 233.50M |
| Delcath Systems | 233.11M |
| SOPHiA GENETICS | 232.39M |